Deerfield Management Company »

Somalogic shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Somalogic shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Somalogic

Tip: Access up to 7 years of quarterly data

All positions including Somalogic held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Somalogic by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $168k 66k 2.53

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Somalogic

Casdin Capital
Nikko Asset Management Americas
Vanguard Group
Millennium Management
Barclays
Balyasny Asset Management
Dimensional Fund Advisors
Kent Lake Capital
Charles Schwab Investment Management
Goldman Sachs Group
Gagnon Securities
Bank of America Corporation
Gagnon Advisors
Redmile Group
Swiss National Bank

View all funds holding Somalogic